Understanding anxiety in intellectual disability
Anxiety in a person with intellectual disability is a clinically meaningful pattern of fear, apprehension, physiological arousal, or avoidance that causes distress or interferes with participation, relationships, learning, health care, or daily life. Intellectual disability is defined by limitations in intellectual functioning and adaptive behavior originating during development; it does not prevent a person from experiencing anxiety or receiving an anxiety-disorder diagnosis. A useful assessment asks what the person fears, what has changed, what their body and behavior communicate, what medical or environmental explanations are present, and which forms of support are accessible. AAIDD definition; NICE NG54.
Anxiety is an ordinary response to uncertainty or threat. It becomes a clinical concern when it is persistent, disproportionate to the context, substantially distressing, or functionally impairing, taking account of the individual's developmental level, communication, circumstances, and actual safety. The diagnosis concerns an anxiety syndrome and its consequences, while support planning also addresses the immediate conditions that make a person feel unsafe. Distinguishing the two helps clinicians avoid both missing treatable anxiety and calling a reasonable reaction to an inaccessible or harmful environment a psychiatric disorder.
People with intellectual disability may experience generalized worry, specific phobias, separation-related fears, social anxiety, panic-like episodes, or anxiety associated with uncertainty, medical procedures, and transitions. The form of anxiety varies with age, health, communication, cognitive profile, social exposure, and personal history. Some people can describe worry clearly; others communicate distress through posture, avoidance, facial expression, disrupted sleep, reduced engagement, repeated questions, or changes in daily routines. The most reliable starting point is the person's own account, supported when necessary by individualized communication methods and carefully interpreted observations. NICE NG54.
Intellectual disability, anxiety symptoms, and psychiatric diagnosis
Intellectual disability and anxiety disorder answer different diagnostic questions. The first describes developmental intellectual and adaptive functioning; the second concerns a pattern of emotional, bodily, cognitive, and behavioral symptoms. Intellectual disability alone does not establish anxiety, and anxiety symptoms alone do not establish a disorder. Clinicians assess the developmental history and current adaptive profile while applying the relevant anxiety criteria and considering whether the syndrome represents a change from the person's usual functioning.
The American Association on Intellectual and Developmental Disabilities defines intellectual disability through limitations in intellectual and adaptive functioning with onset before age 22. Diagnostic systems such as DSM-5-TR and ICD-11 use developmental criteria and clinical judgments in related but not identical ways. Cognitive test scores, communication abilities, and adaptive skills influence how anxiety can be assessed; they do not furnish an automatic explanation for fear or behavioral change. An individual may have substantial intellectual support needs yet make recognizable choices, form preferences, and communicate distress through nonspoken channels.
An anxiety symptom is a report or observable indicator such as persistent apprehension, agitation, muscle tension, fear of a specific situation, or avoidance. A screening result estimates the possibility of a condition and helps decide whether more assessment is needed. A clinical diagnosis requires an appropriately conducted assessment of symptom pattern, duration, distress, impairment, differential explanations, developmental presentation, and personal circumstances. A behavior such as refusing transport or leaving a crowded room is evidence to investigate; its meaning becomes clearer only through context and the person's experience. NICE NG54.
Why anxiety may be overlooked
One clinical hazard is diagnostic overshadowing: symptoms of a co-occurring mental or physical condition can be attributed too readily to intellectual disability. Irritability, repetitive reassurance seeking, loss of previously used skills, reluctance to attend day services, or unexplained distress may be dismissed as baseline disability. A systematic review by Dell'Armo and Tassé identifies diagnostic overshadowing as an important issue in psychological-disorder recognition. A careful clinician investigates changes without assuming a single cause. Dell'Armo and Tassé, 2024.
The opposite error also matters. Someone who refuses a painful procedure, becomes distressed by a threatening caregiver, or avoids a severely overstimulating setting may be responding to an identifiable problem. An anxiety label should never replace assessment for pain, sensory barriers, environmental threats, abuse, disrupted routines, medication effects, or inaccessible instructions. Clinical formulation brings psychiatric findings together with these realities rather than treating every observable behavior as an isolated symptom. NICE NG11.
How anxiety can appear in everyday life
Some manifestations resemble those reported by other patients: worry about future events, fear of separation, autonomic arousal, gastrointestinal discomfort, insomnia, muscle tension, racing thoughts, anticipatory distress, and avoidance. An adult who communicates verbally may describe a fear of losing employment, a parent's illness, or being judged by others. A child may dread a classroom transition or separation at school. The clinician should ask whether the concern reflects a realistic risk and how much suffering or disruption it produces.
Other presentations become apparent through changes in participation rather than through a verbal account. A person may stop attending familiar activities, withdraw from preferred relationships, seek constant reassurance, resist a particular journey, cling to a trusted supporter, repeatedly check an object or schedule, or become visibly tense before predictable demands. Increased need for prompting, reduced self-care, restlessness, unusual vigilance, crying, and sleep disturbance can be associated with anxiety but also occur for many other reasons. Tracking the timing, environment, and person's own response helps establish what the signs mean. NICE NG54.
The significance of change depends on baseline. A person who has always disliked loud environments requires a different formulation from someone who suddenly develops fear of an ordinary walk. An occasional need for reassurance differs from repeated checking that prevents sleep or access to desired activities. When caregivers disagree about the intensity or meaning of signs, clinicians can compare descriptions across home, work, school, and health settings, speak privately with the person when possible, and use direct observations to clarify patterns.
Communication barriers and expressions of distress
Expressive speech, comprehension, literacy, symbolic understanding, and ability to label bodily sensations vary widely across people with intellectual disability. Clinicians should present one question at a time, use familiar vocabulary, allow processing time, check comprehension, and provide suitable pictures, demonstrations, assistive technology, or augmentative and alternative communication. Questions that invite the person to indicate comfort, preferences, and fear may be more informative than abstract inquiries about how frequently they experience anxiety.
Communication support must be individualized. A visual scale may clarify intensity for one person and confuse another; simple yes-or-no questions may encourage acquiescence when the person thinks there is a preferred answer. Some people can distinguish sadness, fear, pain, anger, and excitement; others need examples from daily experiences. Family or support-worker reports add context, but no informant can replace the person's experience. During assessment, private opportunities to communicate can be especially important where fear may be related to interpersonal treatment or coercion. NICE NG54.
How common is anxiety and who is at risk?
Researchers consistently identify anxiety as an important mental-health concern in intellectual disability, although any single prevalence percentage can mislead. Studies vary in age range, diagnostic thresholds, communication accessibility, syndrome composition, informant versus self-report, and whether they count symptoms or diagnosed disorders. A systematic review and meta-analysis of syndromic intellectual disability synthesized 83 papers and 13,708 participants across eight syndromes and found major between-syndrome variation. Those estimates describe selected study populations and should not be extrapolated to everyone with intellectual disability. Edwards et al., 2022.
Risk is shaped by interactions among individual vulnerability, co-occurring health conditions, life experiences, available control, and environmental predictability. Communication barriers can magnify uncertainty or reduce a person's ability to seek reassurance and report mistreatment. Painful medical experiences, bullying, bereavement, relational insecurity, social isolation, exclusion, and unpredictable care may contribute. Some genetic conditions have distinctive group-level anxiety profiles, yet these distributions do not determine the psychiatric status or future of an individual. Comprehensive assessment investigates personal experiences instead of deriving a diagnosis from a syndrome name.
Access to services also changes what researchers see. People with more severe intellectual disability or limited spoken language are often underrepresented in psychological-treatment trials and may have difficulty completing self-report measures. Some apparent prevalence differences therefore reflect ascertainment and measurement. Research should interpret symptom scales, formal diagnoses, and caregivers' concerns as different sources of information, not as interchangeable estimates of clinical disorder.
A clinically sound assessment pathway
Assessment begins by asking the person what is difficult and what outcome would improve their life. A clinician with relevant expertise documents the current concern, onset, pattern, duration, severity, setting, and functional consequences. With the person's consent and appropriate support, the clinician gathers accounts from family members, support workers, teachers, or others who know the person's baseline. The purpose is to understand anxiety in the context of a whole life, rather than to infer distress from one episode. NICE NG54.
A good evaluation establishes a chronological account. What happened before symptoms appeared? Did an illness, painful procedure, relocation, relationship loss, medication change, seizure, staffing change, incident of abuse, or conflict occur? Does the concern arise before certain demands and settle when the situation changes? Are there times when the person is calm, engaged, and comfortable? Responses help distinguish enduring vulnerabilities from recent triggers and identify protective environments.
The clinician reviews psychiatric and developmental history, current medications, sleep, physical health, trauma exposure, communication needs, sensory issues, and relevant family and social circumstances. They examine patterns of avoidance and reassurance seeking and consider whether a specific anxiety disorder meets current diagnostic criteria. Careful assessment may involve several shorter sessions and interdisciplinary input rather than a single standard-length interview. The resulting formulation should make its uncertainty explicit and identify practical, testable targets for support. NICE NG54.
Direct conversation and supported participation
Accessible clinical conversation makes diagnostic work more accurate. Before asking sensitive questions, a professional can explain the purpose of the appointment in plain language, offer a schedule, show pictures of the topics, and check that the person understands they may ask for a break or say they do not know. The person may choose a supporter to attend, use an AAC device, or meet part of the time alone. The clinician avoids leading questions and records the person's language or communicative response as faithfully as possible.
People with intellectual disability should participate in goal setting according to their communication and decision-making preferences. The relevant goals may be going to the doctor without overwhelming fear, taking public transportation, sleeping through the night, attending a favorite community activity, or becoming able to say when a situation feels unsafe. Improvements in functioning and self-determination can matter alongside changes in a symptom scale.
Informant reports and direct observations
Informants can describe when distress occurs, what has recently changed, and how consistently signs appear across settings. Their reports may differ because situations, relationships, demands, or recognition of anxiety vary. Clinicians should investigate discrepancies rather than average them away. A brief, respectful observation record can note antecedents, the person's responses, what happened afterward, and the person's own interpretation where available.
When a person avoids an activity, avoidance may temporarily reduce anxiety and make future engagement harder. It can also signal a reasonable boundary or a threat. Clinicians distinguish these functions before recommending any change. Observations should therefore include indications of pain, sensory overload, coercion, inaccessible communication, and genuine preferences, as well as possible fear-based avoidance. NICE NG11.
Anxiety screening scales and psychometric limits
Screening and symptom-monitoring instruments can structure discussion and document change. Their results require interpretation in relation to language comprehension, intellectual functioning, sensory ability, cultural context, and response style. A score is not a stand-alone anxiety diagnosis. Before using a scale developed for the general population, clinicians should assess whether the wording, format, recall interval, response options, and validation population make sense for the individual. NICE NG54.
The Glasgow Anxiety Scale for People with an Intellectual Disability (GAS-ID) was developed for self-report in people with mild intellectual disability. Its original study found strong internal consistency and test-retest reliability within a small sample and offered an approach to identifying worries, specific fears, and physiological symptoms. These promising properties belong to the studied population and conditions: they should not be treated as proof of equivalent validity in people with severe intellectual disability, those who use substantially different communication systems, or culturally different settings. Mindham and Espie, 2003.
A systematic review by Hermans, van der Pas, and Evenhuis examined 17 studies of 14 anxiety instruments used with adults with intellectual disabilities. The authors identified some promising measures but emphasized limited replication and variable methodological quality. Informant measures can be useful when direct self-report is inaccessible, yet their findings may reflect informant interpretation and interrater disagreement. Multiple methods, baseline comparisons, and clinical evaluation remain essential. Hermans et al., 2011.
Assessment tools designed for broader psychopathology or behavioral distress can help clinicians identify questions needing follow-up, while comprehensive mental-health interviewing evaluates disorder-specific criteria and differential explanations. For children, age-appropriate informant tools may be considered within a developmental assessment. Repeating an accessible measure with the same method can help monitor change, but changes in environment, literacy support, familiarity with testing, and informant identity can affect scores independently of symptom severity.
Differential diagnosis and co-occurring conditions
Physical illness deserves active attention whenever anxiety-like symptoms are new, intense, or accompanied by a change in functioning. Pain, constipation, dental disease, reflux, sleep-disordered breathing, urinary illness, sensory loss, endocrine conditions, and adverse medication effects can manifest through restlessness, distress, withdrawal, or sleep problems. Clinical review should be proportionate to symptoms, history, examination findings, and potential urgency. It is particularly important when someone cannot reliably explain bodily discomfort. NICE NG54.
Anxiety can coexist with depression, obsessive-compulsive disorder, trauma-related disorders, psychosis, autism, ADHD, epilepsy, and other conditions. Their symptoms may overlap: repeated behavior may represent a routine, compulsive ritual, self-regulation, reassurance seeking, or a communication attempt; decreased engagement may result from fear, depression, loss of skills, or illness. Clinicians should examine the temporal pattern, subjective experience, functional consequences, and related syndrome criteria. A general anxiety diagnosis is not a substitute for identifying panic attacks, trauma-related symptoms, or specific fears when those distinctions guide treatment.
Autism, sensory needs, and uncertainty
Co-occurring autism may shape sensory distress, social expectations, tolerance of uncertainty, and communication of internal states. Intellectual disability and autism have distinct diagnostic constructs, and people may meet criteria for either or both. A person can experience fear from an unpredictable schedule or an overwhelming environment without satisfying criteria for a separate anxiety disorder. If a fear pattern produces additional distress and restriction, clinical anxiety may be present alongside autism. The primary assessment focus remains the individual's experience and the effect of available adjustments. Related diagnostic ownership is addressed in the separate published article on autism and intellectual disability in adults.
Trauma, abuse, and environmental safety
Trauma-related anxiety must be approached with accessible, confidential, and non-leading inquiry. A person may develop sudden fear of certain settings or individuals following bullying, mistreatment, inappropriate restraint, exploitation, or loss of a trusted relationship. An immediate safety assessment may be necessary where the person reports harm or circumstances suggest abuse. Support should prioritize safety, rights, and appropriate safeguarding procedures before behavioral exposure to a feared setting. The existence of disability never reduces the seriousness of the person's account. NICE NG11.
Panic, seizures, and medical episodes
Short episodes of trembling, sweating, rapid breathing, or sudden fear can be experienced as panic, but some medical and neurological events can look similar. Clinicians review onset, duration, awareness, recovery, vital symptoms, medications, and seizure history, and seek appropriate medical investigation when clinically indicated. A diagnosis of panic disorder requires more than the observation of physiological arousal. Sudden severe symptoms, collapse, breathing difficulty, chest pain, or a first suspected seizure warrant appropriate urgent medical evaluation rather than routine anxiety management.
An individualized formulation of anxiety
A formulation connects predispositions, precipitating events, maintaining mechanisms, protective factors, and the person's own goals. For example, a young adult who fears a day-service bus may remember a prior frightening journey, lack a reliable way to request a stop, and receive inconsistent advance information. Avoiding the bus may bring immediate relief while shrinking opportunities for participation. A useful plan may begin with restoring communication, predictability, and control; further anxiety-specific treatment can then address persistent fear. The formulation should be revised when new evidence emerges.
This approach prevents an overly narrow medical reading of anxiety and an equally narrow behavioral reading of avoidance. It makes room for biological sensitivity, learning history, social relationships, autonomy, actual safety, and accessible supports. A person may benefit from reducing uncertainty even if they do not meet formal criteria for an anxiety disorder. Others require specialist treatment for a diagnosable anxiety condition in addition to environmental accommodations.
Evidence-based psychological support
Treatment selection follows the anxiety presentation, the person's preferences and communication abilities, clinical severity, co-occurring conditions, and the available evidence. The general anxiety-disorder literature supports several psychological approaches, yet findings from the general population cannot be assumed to transfer unchanged to every level of intellectual disability. NICE recommends considering relaxation techniques for anxiety symptoms and graded exposure for anxiety symptoms or phobias in people with learning disabilities, with adaptations to how interventions are understood, delivered, practiced, and monitored. NICE NG54.
Support can combine collaborative psychological treatment, reliable communication, environmental adjustment, a predictable schedule, opportunities for choice, supportive relationships, and treatment of co-occurring medical concerns. Improving communication or removing an unreasonable demand can markedly change the person's daily experience, regardless of whether an anxiety diagnosis remains. Progress should be defined by reduced distress, greater confidence, meaningful access to chosen activities, and the person's experienced quality of life.
Adapted cognitive behavioral therapy
Cognitive behavioral therapy (CBT) examines how interpretations, bodily responses, emotions, and behavior interact. For people with intellectual disability, adaptations may include shorter sessions, clear vocabulary, concrete examples, visual aids, repetition, modeling, simplified worksheets, supported practice, and flexible pace. The therapist evaluates comprehension continuously and uses the person's preferred way of describing or expressing distress. Trusted supporters can help with between-session practice when the person agrees and privacy remains protected. Poku et al., 2026.
The evidence is encouraging but remains limited. A 2023 systematic review of CBT for anxiety in people with intellectual disability included nine studies, comprising 60 participants; improvements were reported in some individuals, but small and uncontrolled designs constrained causal interpretation. A broader 2023 meta-analysis found methodological weaknesses and imprecision for combined depression-and-anxiety outcomes. These studies support the feasibility of adaptations while leaving important questions about comparative efficacy unanswered. Fynn et al., 2023; Tapp et al., 2023.
An October 2026 systematic review and meta-analysis of randomized trials examined adapted CBT for anxiety separately in autistic participants and people with intellectual disability. Its intellectual-disability subgroup included four studies and found a small immediate benefit (Hedges' g = -0.32; 95% confidence interval -0.62 to -0.01), with low certainty and sensitivity to sample composition. The larger autism subgroup cannot stand in for the ID-specific evidence. These results justify offering appropriately adapted therapies with shared decision-making and outcome monitoring, while avoiding claims of proven long-term benefit in every subgroup. Shao, Han, and Wang, 2026.
Relaxation and bodily regulation
Relaxation approaches may help people notice and manage bodily arousal. Depending on the person, therapy may involve paced breathing, comfortable muscle relaxation, grounding in a familiar environment, adapted visual instruction, or guided practice with a trusted supporter. The aim is to develop a voluntary skill that the person understands and can use. A technique should be adjusted if it produces discomfort or increases monitoring of bodily symptoms. NICE specifically recommends considering relaxation therapy for anxiety symptoms in people with learning disabilities. NICE NG54.
Graded exposure and fear reduction
Graded exposure involves collaboratively approaching a feared but safe situation in manageable steps, learning through experience that the situation can be tolerated and that feared outcomes may not occur. It requires assessment of the fear, genuine safety, capacity to assent or consent with support, communication methods, and realistic goals. A plan might begin with looking at a photo of a medical setting, then visiting briefly, then taking part in a chosen step of an appointment. The pace is governed by the person's understanding and response, with opportunities to stop or reconsider. NICE NG54.
Exposure has no place as a technique for making someone endure mistreatment, painful procedures without appropriate care, threatening environments, or violations of autonomy. It should be supervised by a qualified clinician when fears are severe, trauma is involved, or medical complications are possible. Providing sensory accommodations, clear explanations, and supportive communication is compatible with exposure when these changes improve access rather than perpetuate avoidance.
Communication, environment, and predictability
Supporters can reduce unnecessary distress by explaining changes in advance, offering clear and consistent schedules, making instructions accessible, honoring reasonable preferences, reducing overwhelming sensory demands, and ensuring the person can ask for help. Predictability should increase choice rather than impose a rigid timetable. Collaborative problem-solving may identify a small adjustment that changes an entire experience, such as a quieter waiting space, extra time to prepare for transport, or a reliable communication signal for discomfort.
Where avoidance or distress interferes with everyday activities, a qualified team can also use a functional assessment to understand triggers and consequences. A behavior support plan should address health, communication, environmental conditions, skills, and quality of life. Such assessment complements psychiatric evaluation: identifying an observable behavior's function does not establish or exclude an anxiety disorder. NICE NG11.
Medication and clinical monitoring
Medication may be considered for a diagnosed anxiety disorder when indicated by clinical severity, evidence-based condition-specific guidance, individual preferences, prior treatment response, and accessible follow-up. Prescription decisions require a clinician familiar with the person's intellectual disability, physical health, communication, other medicines, and possible side effects. Standard anxiety-treatment evidence may inform decisions, but ID-specific comparative drug trials are limited. NICE emphasizes specialist oversight in higher-support populations and careful review of interactions, monitoring, and adverse effects. NICE NG54.
Selective serotonin reuptake inhibitors are among medicines used for several anxiety disorders in general psychiatric care. When a clinician chooses one, assessment should establish a target condition and measurable outcomes, explain benefits and harms accessibly, and monitor for activation, sleep disturbance, gastrointestinal effects, behavioral change, suicidal thinking when relevant, and drug interactions. Different clinical situations require different treatment protocols. Neither agitation nor an intellectual-disability diagnosis is an independent reason to prescribe sedating psychotropic medication.
Benzodiazepines and other sedatives can cause sedation, falls, paradoxical disinhibition, tolerance, and dependence, and may make communication or learning more difficult. Antipsychotics are not routine treatment for nonspecific anxiety or behavioral distress. When psychotropic medication is used, the clinician should review indication, dosage, functional effects, adverse events, and opportunities to simplify unnecessary polypharmacy. Medication review belongs in a broader plan addressing psychological, physical, and social determinants of distress. NICE NG54; NICE NG11.
Support for children and adolescents
Children with intellectual disability may have difficulty communicating fears, distinguishing bodily sensations, or predicting what will happen in a new environment. Assessment examines developmental level, family and school context, transitions, medical experiences, accessible classroom instruction, and peer relationships. A child who becomes distressed at school may need both mental-health evaluation and changes to the learning or social environment. Care should consider separation, bullying, sensory demands, communication barriers, and opportunities for ordinary childhood participation.
Approaches can involve developmentally adapted skills, caregiver coaching, clear routines, school collaboration, support for emotional vocabulary and communication, and selective specialist therapy. Evidence for particular anxiety-treatment adaptations in children with intellectual disability is less developed than for mainstream pediatric anxiety populations. NICE identifies research gaps in interventions for internalizing disorders in children and young people with learning disabilities. That uncertainty favors careful individualization, transparent monitoring, and appropriate escalation rather than therapeutic pessimism. NICE NG54 research recommendations.
Support across adult life
Adults may experience anxiety concerning employment, finances, housing, intimate relationships, family illness, unfamiliar professionals, dependence on support systems, or transitions between services. Distress can increase when daily decisions are made without meaningful consultation. Supported decision-making, accessible explanations, reliable relationships, and opportunities to build control are important elements of clinical care. Clinicians should also ask about realistic fears and actual constraints, including exploitation, unwanted restrictions, and discontinuity of care.
Changes in later life require new consideration of physical illness, bereavement, sensory loss, changes in caregivers, and neurocognitive conditions where relevant. A sudden reduction in functioning should prompt a medical and mental-health review rather than being assigned automatically to aging or lifelong disability. Intervention targets should continue to reflect what matters to the person, including relationships, ordinary routines, recreation, community participation, and dignity.
Family members, support staff, and services
Family members and support workers are often the first to notice subtle changes and can make psychological support more accessible by using familiar language and maintaining consistent routines. Their involvement is valuable when the person chooses it and the boundaries of privacy are respected. They need specific guidance: which signs merit monitoring, how to respond to fear without coercion, how to support voluntary practice, and when to seek reassessment. Supporter distress and staffing instability can also affect the environment and deserve practical attention. NICE NG54.
Services should coordinate mental-health professionals, primary care, communication specialists, educators, nurses, and disability-support personnel as needed. Clear division of roles matters: who checks health concerns, who provides adapted therapy, who helps with agreed skills between sessions, who records outcomes, and who reviews medication. Training should include recognition of diagnostic overshadowing and the danger of attributing distress only to a person's diagnosis. Dell'Armo and Tassé, 2024.
Monitoring progress and reassessing the plan
Monitoring should combine the person's reported or communicated experience, a suitable consistent symptom measure when available, participation in valued activities, sleep or daily functioning where relevant, and observed changes across settings. Before treatment, the team can agree on concrete examples of improvement: attending a chosen class, tolerating a necessary examination, asking for help instead of withdrawing, or enjoying a previously avoided activity. Measures should be accessible and interpreted alongside changes in circumstances.
Improvement rarely follows a perfectly linear path. A renewed stressor, an illness, loss of a supporter, or an unsuitable treatment adaptation may change the picture. If anxiety persists or worsens, clinicians review whether the original diagnosis remains convincing, whether trauma or physical illness has been missed, whether therapy matches the person's communication and learning needs, and whether a support plan restricts the person's agency. Failed implementation should not be interpreted as incapacity to benefit from all psychological care.
When urgent assessment is necessary
Sudden behavioral or mental-status change, serious unexplained physical symptoms, inability to maintain basic hydration or safety, an apparent seizure, or acute confusion requires appropriate medical assessment. When suicidal thoughts, suicidal behavior, dangerous self-injury, psychosis, severe agitation, or an immediate safeguarding concern is suspected, the person needs timely assessment by qualified health and emergency services according to urgency. Distinguishing nonsuicidal repetitive self-injury from suicidal intent is important, yet both can carry serious medical risk and deserve individualized evaluation. NICE NG54; NICE NG11.
Crisis care should use the least restrictive safe response, address possible pain or abuse, involve trusted supporters when appropriate, and preserve access to communication. Crisis planning is strongest when the individual can participate, known warning signs are documented, responsibilities are clear, and there is a route to follow-up care after immediate danger passes. An anxiety-focused article cannot replace emergency diagnosis or local safeguarding procedures.
Research quality, uncertainties, and future priorities
The clinical recognition of anxiety as a genuine concern in people with intellectual disability is established. Recommendations to assess distress comprehensively, examine physical health and communication, and offer individualized care are supported by professional guidelines. Specific anxiety-scale validity is more limited across severity levels and cultural settings. Intervention trials often have small samples, inconsistent adaptations, limited follow-up, and underrepresentation of people with substantial communication needs. These distinctions matter when evidence is translated into practice. Hermans et al., 2011; Fynn et al., 2023.
The 2026 CBT meta-analysis provides low-certainty evidence for a small post-treatment anxiety benefit in the intellectual-disability subgroup. The 2026 psychotherapy-adaptation systematic review identifies recurring accessibility strategies across 122 studies, but documenting adaptations is different from proving that each one independently improves outcomes. More rigorous trials should include participants across intellectual and communication profiles, accessible patient-defined outcomes, carefully specified intervention components, relevant comparison groups, longer follow-up, and measures of quality of life and agency. Shao et al., 2026; Poku et al., 2026.
Scientific interpretation also benefits from distinguishing group averages from an individual's likely response. A small average treatment effect does not prevent a particular person from benefiting substantially, and a promising case series does not prove broad efficacy. An ethical and scientifically disciplined service offers reasonable evidence-based options, documents their limits, and evaluates actual outcomes with the person receiving support.
Frequently asked questions
Can a person with intellectual disability have a diagnosable anxiety disorder?
Yes. Intellectual disability and anxiety disorder are separate clinical concepts and can occur together. A diagnosis is based on a suitable assessment of the anxiety syndrome, its duration, distress and functional effects, and relevant medical, psychological, and environmental explanations. Communication accommodations help the person participate. NICE NG54.
Does avoidance always mean anxiety?
No. Avoidance may arise from fear, pain, exhaustion, sensory overload, confusion, trauma, preferences, or an unsafe setting. The reason is investigated through direct communication, history, observation, medical review, and contextual formulation. Any intervention should respect the person's safety and choices. NICE NG11.
Can anxiety be assessed when someone has limited speech?
Yes. Clinical evaluation can use accessible communication, relevant observation, a person's established baseline, physical-health assessment, and reports from supporters who know the person. These sources are combined carefully, and a standardized score alone does not establish a diagnosis. NICE NG54.
Is adapted CBT effective for anxiety in intellectual disability?
Adapted CBT is a reasonable option for selected individuals, particularly when the person can engage with a suitably tailored approach and outcomes are monitored. Research suggests potential benefit, including a small low-certainty effect in a 2026 randomized-trial meta-analysis, while stronger long-term and high-support-needs evidence remains necessary. Shao et al., 2026; Fynn et al., 2023.
What should families do when anxiety seems to appear suddenly?
Document the change, ask the person about their experience in an accessible way, examine recent events and possible distressing conditions, and arrange a health and mental-health review. Sudden severe symptoms or immediate safety concerns require urgent medical attention. A change from baseline deserves investigation rather than attribution to intellectual disability itself.
Is anxiety treated only with medication?
Care may include adapted psychological treatment, graded exposure or relaxation where appropriate, communication access, environmental change, medical treatment for co-occurring causes, and practical support. Medication decisions depend on the diagnosed condition and individualized risk-benefit assessment. NICE NG54.
Related Articles
Mental Health Problems in People With Intellectual Disability: Recognition and Care — broader identification and interdisciplinary clinical care for psychiatric conditions in intellectual disability.
Diagnostic Overshadowing in Intellectual Disability: How Conditions Are Missed — preventing misattribution of new symptoms to an existing developmental diagnosis.
Functional Behavior Assessment in Intellectual Disability: Methods and Examples — contextual behavioral analysis when distress, avoidance, and participation difficulties require an additional functional formulation.
Autism and Intellectual Disability in Adults: Differences and Support — distinct and co-occurring developmental profiles in adult life.
Depression in People With Intellectual Disability: Signs and Treatment — Recognition and treatment of depressive disorders in ID.
Adapted Cognitive Behavioral Therapy for Intellectual Disability — Evidence and adaptations of CBT interventions for people with ID.
References
American Association on Intellectual and Developmental Disabilities. (2021). Defining criteria for intellectual disability. AAIDD.
Dell'Armo, K., and Tassé, M. J. (2024). Diagnostic overshadowing of psychological disorders in people with intellectual disability: A systematic review. American Journal on Intellectual and Developmental Disabilities, 129(2), 116–134.
Edwards, G., Jones, C., Pearson, E., Royston, R., Oliver, C., Tarver, J., Crawford, H., Shelley, L., and Waite, J. (2022). Prevalence of anxiety symptomatology and diagnosis in syndromic intellectual disability: A systematic review and meta-analysis. Neuroscience and Biobehavioral Reviews, 138, 104719.
Fynn, G., Porter, M., Borchard, T., Kazzi, C., Zhong, Q., and Campbell, L. (2023). The effectiveness of cognitive behavioural therapy for individuals with an intellectual disability and anxiety: A systematic review. Journal of Intellectual Disability Research, 67(9), 816–841.
Hermans, H., van der Pas, F. H., and Evenhuis, H. M. (2011). Instruments assessing anxiety in adults with intellectual disabilities: A systematic review. Research in Developmental Disabilities, 32, 861–870.
Mindham, J., and Espie, C. A. (2003). Glasgow Anxiety Scale for people with an Intellectual Disability (GAS-ID): Development and psychometric properties of a new measure for use with people with mild intellectual disability. Journal of Intellectual Disability Research, 47(1), 22–30.
National Institute for Health and Care Excellence. (2015). Challenging behaviour and learning disabilities: Prevention and interventions for people with learning disabilities whose behaviour challenges (NG11). NICE.
National Institute for Health and Care Excellence. (2016). Mental health problems in people with learning disabilities: Prevention, assessment and management (NG54). NICE.
National Institute for Health and Care Excellence. (2016). Mental health problems in people with learning disabilities: Recommendations for research. NICE.
Poku, A. C., Gray, K. M., Hewitt, O., and Langdon, P. E. (2026). Adapting psychological therapies for individuals with intellectual disabilities: A systematic review. Clinical Psychology and Psychotherapy, 33(1), e70202.
Shao, S., Han, D., and Wang, J. (2026). Efficacy of cognitive behavioral therapy for anxiety symptoms in autistic individuals and individuals with intellectual disability: A systematic review and meta-analysis. Research in Autism, 138, 203008.
Tapp, K., Vereenooghe, L., Hewitt, O., Scripps, E., Gray, K. M., and Langdon, P. E. (2023). Psychological therapies for people with intellectual disabilities: An updated systematic review and meta-analysis. Comprehensive Psychiatry, 122, 152372.